1551 - 1560 of 8620 Results
Title
Year
-
OPENTitle: SymposiaJournal Name: European Journal of NeurologyPublisher: WileyVol: 29Issue #: S1Start Page: 6End Page: 19Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ene.15461Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.15461Citation Count: 2
-
OPENTitle: An efficient and scalable synthesis of thiazolo ring fused 2-pyridones using flow chemistryJournal Name: ArkivocPublisher: ARKAT USA, Inc.Vol: 2020Issue #: 7Start Page: 365End Page: 378Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.24820/ark.5550190.p011.445Best OA location URL: https://www.arkat-usa.org/get-file/72918/Citation Count: 0
- Longitudinal clustering analysis and prediction of Parkinson’s disease progression using radiomics and hybrid machine learning2021OPENTitle: Longitudinal clustering analysis and prediction of Parkinson’s disease progression using radiomics and hybrid machine learningJournal Name: Quantitative Imaging in Medicine and SurgeryPublisher: AME Publishing CompanyVol: 12Issue #: 2Start Page: 906End Page: 919Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.21037/qims-21-425Best OA location URL: https://qims.amegroups.com/article/viewFile/78913/pdfCitation Count: 29
- Comparative pharmacovigilance assessment of mortality with pimavanserin in Parkinson disease-related psychosis2021OPENTitle: Comparative pharmacovigilance assessment of mortality with pimavanserin in Parkinson disease-related psychosisJournal Name: Journal of Managed Care & Specialty PharmacyPublisher: Academy of Managed Care PharmacyVol: 27Issue #: 6Start Page: 785End Page: 790Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.18553/jmcp.2021.27.6.785Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10391001Citation Count: 10
- Reprogramming of Nucleotide Metabolism Mediates Synergy between Epigenetic Therapy and MAP Kinase Inhibition2020OPENTitle: Reprogramming of Nucleotide Metabolism Mediates Synergy between Epigenetic Therapy and MAP Kinase InhibitionJournal Name: Molecular Cancer TherapeuticsPublisher: American Association for Cancer Research (AACR)Vol: 20Issue #: 1Start Page: 64End Page: 75Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1158/1535-7163.mct-20-0259Best OA location URL: https://aacrjournals.org/mct/article-pdf/20/1/64/1866868/64.pdfCitation Count: 12
-
RESTRICTEDTitle: Population-specific neuromodulation prolongs therapeutic benefits of deep brain stimulationJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 374Issue #: 6564Start Page: 201End Page: 206Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/science.abi7852Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11098594Citation Count: 127
- Cryptic exon detection and transcriptomic changes revealed in single-nuclei RNA sequencing of C9ORF72 patients spanning the ALS-FTD spectrum2023OPENTitle: Cryptic exon detection and transcriptomic changes revealed in single-nuclei RNA sequencing of C9ORF72 patients spanning the ALS-FTD spectrumJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 146Issue #: 3Start Page: 433End Page: 450Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-023-02599-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-023-02599-5.pdfCitation Count: 29
-
OPENTitle: Genetic Testing for GBA and LRRK2 Mutations: Is it Time for Routine Use?Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: S2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13619Best OA location URL: https://doi.org/10.1002/mdc3.13619Citation Count: 2
-
OPENTitle: Status of Current Biofluid Biomarkers in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: S2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13753Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/129170Citation Count: 4
-
OPENTitle: Is Pathology Always the Diagnostic Gold Standard in Neurodegeneration?Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 8Start Page: 1152End Page: 1153Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13570Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13570Citation Count: 5